Cinacalcet HCl: a calcimimetic agent for the management of primary and secondary hyperparathyroidism

Author： Franceschini Nora Joy Melanie S Kshirsagar Abhijit

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.12, Iss.8, 2003-08, pp. : 1413-1421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cinacalcet HCl: a novel therapeutic for hyperparathyroidism

By de Francisco Angel LM

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 3, 2005-03 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Economic Evaluation of Cinacalcet in the Treatment of Secondary Hyperparathyroidism in Italy

By Eandi Mario

PharmacoEconomics, Vol. 28, Iss. 11, 2010-11 ,pp. : 1041-1054

Adis International

Access to resources Recommend Favorite

Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan

By Iseki Kunitoshi

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 601-610

Informa Healthcare

Access to resources Recommend Favorite

New Perspectives in the Management of Secondary Hyperparathyroidism

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 6, 2007-06 ,pp. : 591-598

Bentham Science Publishers

Access to resources Recommend Favorite

Cinacalcet hydrochloride for the treatment of hyperparathyroidism

By Verheyen Nicolas Pilz Stefan Eller Kathrin Kienreich Katharina Fahrleitner-Pammer Astrid Pieske Burkert Ritz Eberhard Tomaschitz Andreas

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 793-806

Informa Healthcare

Access to resources Recommend Favorite